Department of Anesthesiology and Intensive Care Medicine, University Hospital Ulm, Albert-Einstein- Allee 23, 89081, Ulm, Germany.
Institute of Epidemiology and Medical Biometry, Ulm University, Schwabstraße 13, 89075, Ulm, Germany.
BMC Emerg Med. 2024 Oct 24;24(1):201. doi: 10.1186/s12873-024-01118-3.
Psychiatric emergencies pose a special challenge for emergency physicians. It is known from other areas of medicine that the influence of a doctor's gender can have an impact on the type of treatment and quality of patient care. However, this has not yet been investigated in the context of prehospital care in psychiatric emergencies.
To identify whether the gender of the prehospital emergency physicians has an influence on the "on-scene" time, treatment strategy and on the potential escalation of interventions for patients with a psychiatric diagnosis.
A retrospective cohort analysis of emergency missions with a psychiatric diagnosis was performed between January 1, 2015 and December 31, 2021 at the Department of Emergency Medicine, Department of Anesthesiology and Intensive Care Medicine, University Hospital Ulm, Germany.
2882 emergency missions with a psychiatric indication/prehospital psychiatric diagnosis were studied and divided into: intoxication (n = 1343, 46.6%), suicidal behavior (n = 488, 16.9%), exceptional mental situation (n = 282, 9.8%), agitation (n = 262, 9.1%), anxiety and panic disorders (n = 262, 9.1%) and "psychiatric miscellaneous" (n = 245, 8.5%). Inpatient hospitalization occurred in 67.9% (n = 1958) of emergency missions. Of these, 20.3% (n = 392) were admitted directly to a psychiatric hospital. Male emergency physicians had a slightly longer "on-scene" time for psychiatric emergencies than female emergency physicians (p = 0.024). However, the variance in "on-scene" time for all interventions was significantly greater for female emergency physicians than for male emergency physicians (p = 0.025). Male emergency physicians were significantly more likely than their female counterparts to administer intravenous hypnotics in prehospital psychiatric emergencies (p = 0.001). For psychiatric patients who refused medically indicated inpatient psychiatric admission ("involuntary psychiatric admission"), male and female emergency physicians were equally likely to take the required action (p = 0.522). However, male emergency physicians were significantly more likely to administer an intravenous hypnotic to enforce involuntary admission (p = 0.009).
Similar to other medical specialties where the influence of physician gender on patient care is certainly relevant, the gender of prehospital emergency physicians also appears to influence their prehospital management strategy in psychiatric emergencies. The influence of gender is sometimes subtle and limited to specific aspects, such as the administration of hypnotics. Prospective study designs are needed to thoroughly investigate the influence of the gender of the prehospital emergency physician on the quality of care in psychiatric emergencies.
The study was approved by the ethics committee of the University Ulm, Trial-Code No. 110/22 and was prospectively registered in the German Clinical Trials Register (DRKS-ID: DRKS00031237). Patient information was not required for retrospective data analysis.
精神科急症给急诊医生带来了特殊的挑战。从其他医学领域可知,医生的性别会影响治疗类型和患者护理质量。然而,这在精神科急症的院前护理中尚未得到研究。
确定院前急救医生的性别是否会影响有精神科诊断的患者的“现场”时间、治疗策略以及干预措施的潜在升级。
对德国乌尔姆大学医院急诊医学系和麻醉学与重症监护医学系于 2015 年 1 月 1 日至 2021 年 12 月 31 日期间进行的有精神科诊断的紧急任务进行回顾性队列分析。
研究了 2882 次有精神科指征/院前精神科诊断的紧急任务,并分为:中毒(n=1343,46.6%)、自杀行为(n=488,16.9%)、特殊精神状态(n=282,9.8%)、激动(n=262,9.1%)、焦虑和恐慌症(n=262,9.1%)和“精神科杂项”(n=245,8.5%)。67.9%(n=1958)的紧急任务需要住院治疗。其中,20.3%(n=392)直接被送往精神病院。男性急救医生处理精神科急症的“现场”时间比女性急救医生略长(p=0.024)。然而,女性急救医生在所有干预措施的“现场”时间方差明显大于男性急救医生(p=0.025)。男性急救医生在院前精神科急症中更有可能比女性急救医生给予静脉镇静剂(p=0.001)。对于拒绝接受医学上规定的住院精神科治疗(“非自愿精神科治疗”)的精神科患者,男性和女性急救医生采取所需行动的可能性相同(p=0.522)。然而,男性急救医生更有可能给予静脉镇静剂以强制非自愿入院(p=0.009)。
与其他医学专业一样,医生性别对患者护理的影响肯定是相关的,院前急救医生的性别似乎也会影响他们在精神科急症中的院前管理策略。性别的影响有时是微妙的,仅限于特定方面,例如催眠的给予。需要前瞻性研究设计来彻底研究院前急救医生性别的影响对精神科急症护理质量的影响。
该研究得到了乌尔姆大学伦理委员会的批准,试验代码为 110/22,并在德国临床试验注册处(DRKS-ID:DRKS00031237)进行了前瞻性注册。回顾性数据分析不需要患者信息。